"Avastin and Erbitux ... in combination with other chemotherapy drugs can shrink tumors, restrain tumor growth and, in the case of Avastin, extend life by a few months in some patients with colon cancer. ... There is just one big problem: Both drugs have been marketed at such extraordinarily high prices that many people will simply not be able to afford them. Perhaps their legendary political clout in Washington has convinced drug companies that they can price their goods at arbitrarily high levels. ... They are effectively daring the government to impose price controls."
-Physician Robert Wittes, Washington Post
